...
首页> 外文期刊>Nucleic acids research >Analysis of inhibitory action of modified U1 snRNAs on target gene expression: discrimination of two RNA targets differing by a 1 bp mismatch
【24h】

Analysis of inhibitory action of modified U1 snRNAs on target gene expression: discrimination of two RNA targets differing by a 1 bp mismatch

机译:修饰的U1 snRNA对靶基因表达的抑制作用分析:区分两个RNA靶,其差异为1 bp

获取原文
   

获取外文期刊封面封底 >>

       

摘要

The modified U1 snRNA gene can suppress expression of a target transgene. In the present study, its potential utility to inhibit a dominant negative/gain of function mutation is explored. Using a green fluorescent protein (GFP) target gene, inhibition was achieved in all cells transduced with U1antiGFP directed at multiple sites within GFP. Using a chloramphenicol acetyltransferase (CAT) target gene, inhibition was not increased by increasing the hybridization domain from 10 to 16 bp or when a site in an upstream exon or intron was targeted. To determine if a U1 anti-target design could discriminate between two transcripts that differ by a 1–2 bp mismatch, GFPtpz and GFPsaph were chosen as targets because they share sequence homology except for three regions where a 1, 2 or 3 bp mismatch exists. The results demonstrated that U1antiGFP correctly reduced its cognate GFP expression by 90% and therefore U1 anti-target constructs are able to discriminate a 1 or 2 bp mismatch in their target mRNA. Thus, these U1 anti-target constructs may be effective in a strategy of somatic gene therapy for a dominant negative/gain of function mutation due to the discreteness of its discrimination. It may complement other anti-target strategies to reduce the cellular load of a mutant transcript.
机译:修饰的U1 snRNA基因可以抑制靶转基因的表达。在当前的研究中,其潜在的效用被抑制抑制功能突变的显性负/增益。使用绿色荧光蛋白(GFP)靶基因,在针对GFP中多个位点的U1antiGFP转导的所有细胞中均实现了抑制。使用氯霉素乙酰基转移酶(CAT)靶基因时,通过将杂交域从10 bp增加到16 bp或靶向上游外显子或内含子中的位点,抑制作用不会增加。为了确定U1抗靶标设计是否可以区分相差1–2 bp的两个转录本,选择了GFPtpz和GFPsaph作为靶标,因为它们共享序列同源性,除了三个区域中存在1、2或3 bp错配。结果表明,U1antiGFP正确地将其同源GFP表达降低了90%以上,因此U1抗靶标构建体能够区分其靶​​mRNA中的1或2 bp错配。因此,由于其辨别力的离散性,这些U1抗靶构建体在体细胞基因治疗策略中对于显性的负功能突变/增益突变可能是有效的。它可以补充其他抗靶标策略,以减少突变体转录本的细胞负荷。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号